Overview of the use of combined estrogen-progestin oral contraceptives | |
---|---|
Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies | Risks and side effects associated with combined estrogen-progestin oral contraceptives |
Hormonal contraception for suppression of menstruation | Plan B One-Step levonorgestrel tablet package insert, updated July 2017 |
---|---|
Oral contraceptive use and risk of breast cancer | : Afaxys Pharma LLC; 2018 |
Patient education: Emergency contraception morning after pill Beyond the Basics.